Showing results (1881-1890 of 2,406) with videos related to

Sort By:
Pageof 241
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 5, 2021
Piperaquine-Induced QTc Prolongation Decreases With Repeated Monthly Dihydroartemisinin-Piperaquine Dosing in Pregnant Ugandan WomenEmma Hughes, Erika Wallender, Richard Kajubi, et al.
ACS Nano|August 10, 2019
Aluminum Nanocubes Have Sharp CornersBenjamin D Clark, Christian R Jacobson, Minhan Lou, et al.
The Journal of Infectious Diseases|February 10, 2009
Decreasing efficacy of antimalarial combination therapy in Uganda is explained by decreasing host immunity rather than increasing drug resistanceBryan Greenhouse, Madeline Slater, Denise Njama-Meya, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 15, 2016
Implementation and Operational Research: Population-Based Active Tuberculosis Case Finding During Large-Scale Mobile HIV Testing Campaigns in Rural UgandaEmmanuel Ssemmondo, Florence Mwangwa, Joel L Kironde, et al.
Journal of the American Chemical Society|October 31, 2018
Polymer-Directed Growth of Plasmonic Aluminum NanocrystalsShaoyong Lu, Hua Yu, Samuel Gottheim, et al.
The Journal of Head Trauma Rehabilitation|May 6, 2024
Associations Between Traumatic Brain Injury and Severity of Tinnitus-Related Functional Impairment Among US Military Veterans: A National, Population-Based StudyLaura Coco, Elizabeth R Hooker, Tess A Gilbert, et al.
Journal of Vascular Surgery|September 1, 1990
Carotid patch angioplasty: immediate and long-term resultsD Rosenthal, J P Archie, R Garcia-Rinaldi, et al.
Influenza and Other Respiratory Viruses|May 21, 2025
A Systematic Review of Prolonged SARS-CoV-2 Shedding in Immunocompromised PersonsRebecca C Christofferson, Jennifer E Giovanni, Emily H Koumans, et al.
Nucleic Acids Research|October 11, 2014
The immune epitope database (IEDB) 3.0Randi Vita, James A Overton, Jason A Greenbaum, et al.
Journal of Medicinal Chemistry|September 3, 1993
2-(Quinuclidin-3-yl)pyrido[4,3-b]indol-1-ones and isoquinolin-1-ones. Potent conformationally restricted 5-HT3 receptor antagonistsR D Clark, A B Miller, J Berger, et al.
Pageof 241